On December 9, 2019, HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.61 CNY | +0.90% | 0.00% | -28.26% |
1st Jan change | Capi. | |
---|---|---|
-28.26% | 448M | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+18.62% | 5.38B | |
+1.10% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B | |
+7.58% | 3.2B |
- Stock Market
- Equities
- 600829 Stock
- News HPGC Renmintongtai Pharmaceutical Corporation
- HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.